Patients with ACS receiving drug-eluting stent (DES) or bare-metal stent (BMS) were analyzed in this retrospective cohort study in Veterans Health Administration hospitals from 2003 to 2004. American Heart Journal
Patients with type 2 diabetes taking a weekly regimen of the antidiabetes drug exenatide experienced greater changes in hemoglobin A1c levels and were more likely to reach target glucose levels. Medscape Medical News
Diligent attention to early corticosteroid minimization and withdrawal and calcineurin inhibitor-sparing immunosuppression is important to maximize long-term allograft survival in the heart transplant recipient. Medscape Transplantation